Toutes les vidéos
House of Lords 19 mai 2026
Science and Technology Committee
À propos
Subject: Innovation in the NHS: personalised medicine and AI Witness(es): Dr Christian Itin, Chief Executive Officer, Autolus Therapeutics; Professor Peter Donnelly, Chief Executive Officer, Genomics plc Witness(es): Dr Michalis Papadakis, Chief Executive Officer and Co-Founder, Brainomix; Dr Phil L'Huillier, Chief Executive Officer, Scancell
Intervenants
PD Peter Donnelly Chief Executive Officer, Genomics plc
PL Phil L'Huillier Chief Executive Officer, Scancell
CI Christian Itin Chief Executive Officer, Autolus Therapeutics
MP Michalis Papadakis Chief Executive Officer and Co-Founder, Brainomix